ClinicalTrials.gov
public full text
Public Domain
Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
The LEAP-SE study will be conducted to validate the utility of EEG biomarkers as an aid to antidepressant treatment selection in adults with MDD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial#897988
- Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)#832275
- EEG Biomarkers for Predicting Response to Antidepressant Therapy#827439
- A multidimensional astrocytic framework links serum biomarkers to depression subtypes cognition and sleep EEG.#297333
- Predicting antidepressive treatment outcome using machine learning analysis of EEG data: the importance of independent feature selection#462509
Record · ID 1165193
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive